Transoral robotic surgery for oropharyngeal squamous cell carcinoma

Nicole C. Schmitt, Umamaheswar Duvvuri

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Purpose of review This article reviews recent information on outcomes, indications, techniques, and cost of transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC). New information on comparisons between TORS, conventional surgery techniques, and chemoradiation is also highlighted. Recent findings Consistent with prior reports, recent studies show excellent oncologic and functional outcomes with TORS for OPSCC. As surgeon experience with this relatively new technique has increased, outcomes continue to improve and complications are rare. TORS may also have a role in management of carcinoma of unknown primary site. Compared with other treatment modalities, TORS for OPSCC may result in similar oncologic outcomes, improved functional outcomes, and decreased cost. Summary TORS for OPSCC results in excellent functional and oncologic outcomes. Randomized clinical trials are needed to compare TORS with adjuvant therapy to definitive chemoradiation and will determine whether adjuvant therapy and associated morbidity can be decreased without compromising survival.

Original languageEnglish (US)
Pages (from-to)127-131
Number of pages5
JournalCurrent Opinion in Otolaryngology and Head and Neck Surgery
Issue number2
StatePublished - Jan 1 2015


  • oropharyngeal squamous cell carcinoma
  • transoral robotic surgery
  • unknown primary carcinoma

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology


Dive into the research topics of 'Transoral robotic surgery for oropharyngeal squamous cell carcinoma'. Together they form a unique fingerprint.

Cite this